Fundz

Neuronetics

Malvern, Pennsylvania, United States · Healthcare, Health Care

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Malvern, Pennsylvania, United States
Employees
51
Industries
Healthcare, Health Care
Status
Public (STIM)
Website
neuronetics.com
LinkedIn
Company page

Recent activity at Neuronetics

  • : SEC 8-K (1.01): On November 10, 2026, Neuronetics, Inc. entered into a Material Definitive Agreement by signing an Underwriting Agreement with William Blair & Company, L.L.C., whereby the Company agreed to issue and sell 18,750,000 shares of its common stock at a public price of $1.60 per share. The offering is expected to close on November 12, 2026, pending customary closing conditions. The estimated net proceeds from the offering will be approximately $27.7 million, which the Company plans to use to repay part of its outstanding term loans under a Credit Agreement with Perceptive Credit Holdings IV, LP, and for various corporate purposes including sales, marketing, and potential acquisitions. The Underwriters also have a 30-day option to purchase an additional 2,812,500 shares at the same price.
  • : SEC 8-K (1.01): On November 5, 2026, Neuronetics, Inc. entered into Amendment No. 6 to its Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP. This amendment modifies certain revenue covenants and stipulates conditions for an optional prepayment of at least $15,000,000, among other terms. Notably, if these conditions are not satisfied by November 30, 2026, the amendment will automatically terminate, indicating its strategic importance to the company's financial management. This agreement follows a previous credit arrangement established on July 25, 2024, highlighting the ongoing financial relationship between Neuronetics and Perceptive.
  • : SEC 8-K (7.01): On November 4, 2026, the Company released a presentation intended for certain investors, which outlines forward-looking statements regarding its business outlook for upcoming fiscal years. The presentation includes the Company’s expectations related to revenue, expenses, and growth, explicitly noting the potential impact of its transaction with Greenbrook TMS Inc. The filing contains a cautionary statement regarding risks and uncertainties that could affect these forward-looking statements. As it was released on the same day, it falls within the 3-day window for SEC disclosures.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Employee benefit plans

Neuronetics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

About Neuronetics: questions and answers

Where is Neuronetics headquartered?

Neuronetics is headquartered in Malvern, Pennsylvania, United States.

How many employees does Neuronetics have?

Neuronetics has about 51 employees.

What is the latest news on Neuronetics?

On Nov 4, 2026, SEC 8-K (1.01): On November 10, 2026, Neuronetics, Inc. entered into a Material Definitive Agreement by signing an Underwriting Agreement with William Blair & Company, L.L.C., whereby the Company agreed to issue and sell 18,750,000 shares of its common stock at a public price of $1.60 per share. The

Is Neuronetics a public company?

Yes. Neuronetics is publicly traded under the ticker STIM.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Neuronetics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.